@finner @kDelta An example here is that the US spends more on end-of-life care than most. It's important to not spend crazy amount of resources keeping someone alive (often with a poor QOL).
Large parts of the population (probably those with decent insurance :p) also seek medical care far quicker than most developed nations (despite the cost).
Patent law is another issue, the fact that you can re-patent a drug by adding an arbitrary ingredient prevents competition in the drug production market
@finner @kDelta Anecdotally I've also been told from doctors who've worked both in Europe and the US that US patients are harder to convince that they can just go home and sit it out. Which costs health insurances money that could be going to reducing deductibles for example :-).